Tonix Pharmaceuticals Holding (TNXP) Receivables (2023 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Receivables of $12.2 million for Q1 2026, up 165.38% year-over-year from $4.6 million in Q1 2025, and up 25.15% quarter-over-quarter from $9.8 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Receivables (2023 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Receivables history runs 4 years deep, the most recent figure standing at $12.2 million for Q1 2026.
- In Q1 2026, Receivables rose 165.38% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $12.2 million (up 165.38% YoY), while the FY2025 annual figure was $9.8 million, up 110.44% from the prior year.
- Receivables for Q1 2026 stood at $12.2 million, up from $9.8 million in the prior quarter.
- The five-year high for Receivables was $12.2 million in Q1 2026, with the low at $1.6 million in Q3 2023.
- The 4-year median for Receivables is $4.6 million (2024), against an average of $5.8 million.
- The sharpest annual moves came in 2024 and 2026: Receivables tumbled 49.5% in 2024, then jumped 165.38% in 2026.
- Tonix Pharmaceuticals Holding's Receivables stood at $9.2 million in 2023, then slumped by 49.5% to $4.6 million in 2024, then surged by 110.44% to $9.8 million in 2025, then grew by 25.15% to $12.2 million in 2026.
- Business Quant data shows TNXP's Receivables at $12.2 million in Q1 2026, $9.8 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 15.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.05 Mn |
| Mar 31, 2026 | 12.21 Mn |
| Dec 31, 2025 | 9.76 Mn |
| Sep 30, 2025 | 5.15 Mn |
| Jun 30, 2025 | 4.22 Mn |
| Mar 31, 2025 | 4.60 Mn |
| Dec 31, 2024 | 4.64 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Dec 31, 2023 | 9.18 Mn |
| Sep 30, 2023 | 1.56 Mn |